Literature DB >> 23616662

Human papillomavirus types 16, 18, and 31 share similar endocytic requirements for entry.

Gilles Spoden1, Lena Kühling, Nicole Cordes, Bettina Frenzel, Martin Sapp, Klaus Boller, Luise Florin, Mario Schelhaas.   

Abstract

Human papillomavirus type 18 (HPV18), one of the HPVs with malignant potential, enters cells by an unknown endocytic mechanism. The key cellular requirements for HPV18 endocytosis were tested in comparison to those for HPV16 and -31 endocytoses. HPV18 (like HPV16 and -31) entry was independent of clathrin, caveolin, dynamin, and lipid rafts but required actin polymerization and tetraspanin CD151, and the viruses were routed to the same LAMP-1-positive compartment. Hence, the viruses shared similar cellular requirements for endocytic entry.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23616662      PMCID： PMC3700296          DOI： 10.1128/JVI.00370-13

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  49 in total

1.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 2.  Tetraspanins.

Authors:  C Boucheix; E Rubinstein
Journal:  Cell Mol Life Sci       Date:  2001-08       Impact factor: 9.261

3.  Constitutive macropinocytosis in oncogene-transformed fibroblasts depends on sequential permanent activation of phosphoinositide 3-kinase and phospholipase C.

Authors:  M Amyere; B Payrastre; U Krause; P Van Der Smissen; A Veithen; P J Courtoy
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 4.  Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes.

Authors:  María Yáñez-Mó; Olga Barreiro; Mónica Gordon-Alonso; Mónica Sala-Valdés; Francisco Sánchez-Madrid
Journal:  Trends Cell Biol       Date:  2009-08-24       Impact factor: 20.808

5.  Saturable binding sites for vesicular stomatitis virus on the surface of Vero cells.

Authors:  R Schlegel; M C Willingham; I H Pastan
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

6.  Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive.

Authors:  Valerie Laniosz; Sarah A Dabydeen; Mallory A Havens; Patricio I Meneses
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

Review 7.  Mechanisms of endocytosis.

Authors:  Gary J Doherty; Harvey T McMahon
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

Review 8.  Specific tetraspanin functions.

Authors:  M E Hemler
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

9.  Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization.

Authors:  David K Cureton; Ramiro H Massol; Saveez Saffarian; Tomas L Kirchhausen; Sean P J Whelan
Journal:  PLoS Pathog       Date:  2009-04-24       Impact factor: 6.823

10.  Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs).

Authors:  Gilles Spoden; Kirsten Freitag; Matthias Husmann; Klaus Boller; Martin Sapp; Carsten Lambert; Luise Florin
Journal:  PLoS One       Date:  2008-10-02       Impact factor: 3.240
View more
  45 in total

1.  Human Papillomavirus Infectious Entry and Trafficking Is a Rapid Process.

Authors:  Justyna Broniarczyk; Paola Massimi; Martina Bergant; Lawrence Banks
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

Review 2.  Cruising the cellular highways: How human papillomavirus travels from the surface to the nucleus.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G Guion; Martin Sapp
Journal:  Virus Res       Date:  2016-10-29       Impact factor: 3.303

3.  The nuclear retention signal of HPV16 L2 protein is essential for incoming viral genome to transverse the trans-Golgi network.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lydia Hilbig; Martin Sapp
Journal:  Virology       Date:  2014-05-08       Impact factor: 3.616

4.  Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection.

Authors:  Konstantin H Müller; Gilles A Spoden; Konstanze D Scheffer; Regina Brunnhöfer; Jef K De Brabander; Martin E Maier; Luise Florin; Claude P Muller
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

5.  Extracellular Conformational Changes in the Capsid of Human Papillomaviruses Contribute to Asynchronous Uptake into Host Cells.

Authors:  Miriam Becker; Lilo Greune; M Alexander Schmidt; Mario Schelhaas
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

6.  Human Papillomavirus infection requires the CCT Chaperonin Complex.

Authors:  Marina Bugnon Valdano; Paola Massimi; Justyna Broniarczyk; David Pim; Michael Myers; Daniela Gardiol; Lawrence Banks
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

7.  Human keratinocyte cultures in the investigation of early steps of human papillomavirus infection.

Authors:  Laura M Griffin; Louis Cicchini; Tao Xu; Dohun Pyeon
Journal:  Methods Mol Biol       Date:  2014

Review 8.  Concepts of papillomavirus entry into host cells.

Authors:  Patricia M Day; Mario Schelhaas
Journal:  Curr Opin Virol       Date:  2013-12-14       Impact factor: 7.090

9.  The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.

Authors:  Elena Wüstenhagen; Laura Hampe; Fatima Boukhallouk; Marc A Schneider; Gilles A Spoden; Inka Negwer; Kaloian Koynov; W Martin Kast; Luise Florin
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.